Ledger.Open graph →

SEC Form D · filed April 8, 2020

Aclaris Therapeutics, Inc

Offering

$11.4M

Sold

$11.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WAYNE, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Andrew Schiff · Wayne, PADirector Anand Mehra · Wayne, PADirector Neal Walker · Wayne, PAExec · Director Vincent Milano · Wayne, PADirector William Humphries · Wayne, PADirector Christopher Molineaux · Wayne, PADirector Maxine Gowen · Wayne, PADirector Kamil Ali-Jackson · MALVERN, PAExec Frank Ruffo · MALVERN, PAExec David Gordon · Sydney, NSW, Channel IslandsExec Bryan Reasons · Wayne, PADirector Andrew Powell · Santa Clara, CADirector David Gordon · Waltham, MAExec Kamil Ali-Jackson · Malvern, PAExec Bryan Reasons · Wayne, PADirector Andrew Powell · Santa Clara, CADirector Frank Ruffo · MALVERN, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗